Biodexa Pharmaceuticals ( NASDAQ: BDRX ) announces a ratio change on its American Depositary Receipts from one ADR representing four hundred ordinary shares, to the new ratio of one ADR representing ten thousand ordinary shares. The effective date of the Ratio Change is expected.
Back to Health Page
